Trial intelligence / Profile preview

Botox Alone vs Botox Combined With Fissurectomy and Anoplasty for Chronic Anal Fissure

NCT07665528Recruiting

Sponsor
Islamabad Medical and Dental College
Start
Jun 2026
Primary completion
Sep 2026
Countries
1
01

Overview

Open-label trial of botulinum toxin type A in chronic anal fissure (CAF) (2 arms), sponsored by Islamabad Medical and Dental College. Primary endpoint: Fissure Healing Rate at 3 months. Started Jun 2026; status: recruiting.

02

Drugs

botulinum toxin type A
03

Conditions

chronic anal fissure (CAF)

Beyond the preview

Go deeper on NCT07665528.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07665528.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call